Dignify Therapeutics Inc is categorized under Wholesale Pharmaceutical Products in Durham, NC and active since 2013.
Dignify Therapeutics Inc was established in 2013, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Edward Burgard at the company’s single location by writing to 2 Davis Drive, Durham, North Carolina NC 27709 or by phoning (919) 371-8138. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Dignify Therapeutics Inc |
| Contact Person: | Edward Burgard |
| Address: | 2 Davis Drive, Durham, North Carolina 27709 |
| Phone Number: | (919) 371-8138 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Dignify Therapeutics Inc was started in 2013 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Edward Burgard for inquiries that concern Dignify Therapeutics Inc by calling the company number (919) 371-8138, as your correspondence is most welcome. Additionally, the physical location of the single location of Dignify Therapeutics Inc can be found at the coordinates 35.903449,-78.858091 as well as the street address 2 Davis Drive in Durham, North Carolina 27709.
For its online presence, you may visit Dignify Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.